Frontiers in Immunology (Jun 2020)

Transplant Tolerance Induction: Insights From the Liver

  • Helong Dai,
  • Helong Dai,
  • Helong Dai,
  • Yawen Zheng,
  • Yawen Zheng,
  • Yawen Zheng,
  • Yawen Zheng,
  • Angus W. Thomson,
  • Angus W. Thomson,
  • Natasha M. Rogers,
  • Natasha M. Rogers,
  • Natasha M. Rogers,
  • Natasha M. Rogers

DOI
https://doi.org/10.3389/fimmu.2020.01044
Journal volume & issue
Vol. 11

Abstract

Read online

A comparison of pre-clinical transplant models and of solid organs transplanted in routine clinical practice demonstrates that the liver is most amenable to the development of immunological tolerance. This phenomenon arises in the absence of stringent conditioning regimens that accompany published tolerizing protocols for other organs, particularly the kidney. The unique immunologic properties of the liver have assisted our understanding of the alloimmune response and how it can be manipulated to improve graft function and survival. This review will address important findings following liver transplantation in both animals and humans, and how these have driven the understanding and development of therapeutic immunosuppressive options. We will discuss the liver's unique system of immune and non-immune cells that regulate immunity, yet maintain effective responses to pathogens, as well as mechanisms of liver transplant tolerance in pre-clinical models and humans, including current immunosuppressive drug withdrawal trials and biomarkers of tolerance. In addition, we will address innovative therapeutic strategies, including mesenchymal stem cell, regulatory T cell, and regulatory dendritic cell therapy to promote liver allograft tolerance or minimization of immunosuppression in the clinic.

Keywords